Soligenix - Stock Price History | SNGX
Historical daily share price chart and data for Soligenix since 2021 adjusted for splits. The latest closing stock price for Soligenix as of September 24, 2021 is 1.02.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Soligenix stock closing price was 4.15 on April 21, 2017.
- The Soligenix 52-week high stock price is 2.80, which is 174.5% above the current share price.
- The Soligenix 52-week low stock price is 0.85, which is 16.7% below the current share price.
- The average Soligenix stock price for the last 52 weeks is 1.46.
|Soligenix Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ? (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.